SCHEMBL6801953

SCHEMBL6801953

O=C(Nc1ccc2c(c1)CCN2C(=O)Cc1ccccn1)c1ccc(Cl)cc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMO Q99835 2/20 0.52
HTR2C P28335 4/20 0.49
HTR2B P41595 4/20 0.49
HTR2A P28223 3/20 0.49
EIF2AK3 Q9NZJ5 1/20 0.45
MTTP P55157 4/20 0.44
APOB P04114 4/20 0.44
RHOC P08134 1/20 0.44
RHOA P61586 1/20 0.44
RIPK1 Q13546 1/20 0.42
GCGR P47871 1/20 0.42
NR3C1 P04150 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6805188 0.93 HTR2C (0.51) SMOHTR2CHTR2BHTR2AEIF2AK3
SCHEMBL6804688 0.92 SMO (0.61) SMOHTR2CHTR2BHTR2AEIF2AK3
SCHEMBL6803858 0.92 SMO (0.52) SMOHTR2CHTR2BHTR2AEIF2AK3
SCHEMBL6808934 0.92 SMO (0.52) SMOHTR2CHTR2BHTR2AEIF2AK3
SCHEMBL6798695 0.90 HTR2C (0.49) SMOHTR2CHTR2BHTR2AEIF2AK3
SCHEMBL6805251 0.90 SMO (0.50) SMOHTR2CHTR2BHTR2AEIF2AK3
SCHEMBL6804573 0.89 SMO (0.51) SMOHTR2CHTR2BHTR2AEIF2AK3
SCHEMBL6803201 0.89 HTR2A (0.49) SMOHTR2CHTR2BHTR2AEIF2AK3
SCHEMBL6666430 0.89 SMO (0.49) SMOHTR2CHTR2BHTR2AEIF2AK3
SCHEMBL6804640 0.88 SMO (0.50) SMOHTR2CHTR2BHTR2AEIF2AK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157866-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157866-A1 Amide compounds APOB, NR1H2, NR1H3 SMO 4390/4885HTR2C 2433/4885HTR2B 928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.